Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
Role of maternal factors in autism; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 17 November.
Neurophysiology data-sharing system faces funding cliff
After the primary grant supporting Neurodata Without Borders ends in March 2026, the platform may no longer be maintained or kept up to date.
Neurophysiology data-sharing system faces funding cliff
After the primary grant supporting Neurodata Without Borders ends in March 2026, the platform may no longer be maintained or kept up to date.
A change at the top of SfN as neuroscientists gather in San Diego
Kevin B. Marvel, longtime head of the American Astronomical Society, will lead the Society for Neuroscience after a year of uncertainty in the neuroscience field.
A change at the top of SfN as neuroscientists gather in San Diego
Kevin B. Marvel, longtime head of the American Astronomical Society, will lead the Society for Neuroscience after a year of uncertainty in the neuroscience field.